• Exchange: OTC US
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharmaceuticals

VG Life Sciences Inc

+ Add to Watchlist


0.1650 USD 0.0070 4.43%

As of 20:10:00 ET on 07/31/2014.

Snapshot for VG Life Sciences Inc (VGLS)

Open: 0.1600 Day's Range: 0.1600 - 0.1650 Volume: 165,784
Previous Close: 0.1580 52wk Range: 0.0500 - 0.5800 1-Yr Rtn: +94.40%

Stock Chart for VGLS

No chart data available.
  • VGLS:US 0.1650
  • 1D
  • 1M
  • 1Y
Interactive VGLS Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for VGLS

Current P/E Ratio (ttm) -
Estimated P/E(12/2007) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -18.0000
Est. EPS (USD) (12/2007) -
Est. PEG Ratio -
Market Cap (M USD) 0.04
Shares Outstanding (M) 0.25
30 Day Average Volume 83,931
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement -
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for VGLS

No data available

Company Profile & Key Executives for VGLS

VG Life Sciences Inc. discovers, develops, and commercializes protein-based therapeutic and diagnostic products with applications in infectious disease, autoimmune conditions, and immunological deficiency. The Company has completed clinical trials of its primary product, VGV-1, an HIV/AIDS treatment and is preparing to file an IND with the USFDA.

Haig KeledjianChairman/President/CEOMonica OrdSenior VP:Corporate Dev
More Company Profile & Key Executives for VGLS

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Sponsored Links
sec ||= nil